Evoke Pharma Inc Drug Patent Portfolio

Evoke Pharma Inc owns 1 orange book drug protected by 5 US patents Given below is the list of Evoke Pharma Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8334281 Nasal formulations of metoclopramide 16 May, 2030
Active
US11020361 Nasal formulations of metoclopramide 22 Dec, 2029
Active
US11628150 Nasal formulations of metoclopramide 22 Dec, 2029
Active
US11813231 Nasal formulations of metoclopramide 22 Dec, 2029
Active
US6770262 Nasal administration of agents for the treatment of gastroparesis 29 Mar, 2021 Expired


Given below is the list of recent legal activities going on the following drug patents of Evoke Pharma Inc.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 05 Jun, 2024 US8334281
Email Notification 08 Dec, 2023 US8334281
Change in Power of Attorney (May Include Associate POA) 08 Dec, 2023 US8334281
Email Notification 01 Dec, 2023 US11020361
Email Notification 01 Dec, 2023 US11813231
Email Notification 01 Dec, 2023 US11628150
Change in Power of Attorney (May Include Associate POA) 01 Dec, 2023 US11813231
Change in Power of Attorney (May Include Associate POA) 01 Dec, 2023 US11628150
Change in Power of Attorney (May Include Associate POA) 01 Dec, 2023 US11020361
Mail Patent eGrant Notification 14 Nov, 2023 US11813231
Email Notification 14 Nov, 2023 US11813231
Patent Issue Date Used in PTA Calculation 14 Nov, 2023 US11813231
Recordation of Patent eGrant 14 Nov, 2023 US11813231
Patent eGrant Notification 14 Nov, 2023 US11813231
Recordation of Patent Grant Mailed 14 Nov, 2023 US11813231


Evoke Pharma Inc's Family Patents

Evoke Pharma Inc drugs have patent protection in a total of 7 countries. It has a significant patent presence in the US with 55.6% of its patents being US patents. Click below to unlock the full patent family tree.

Family Patents



Evoke Pharma Inc Drug List

Given below is the complete list of Evoke Pharma Inc's drugs and the patents protecting them.


1. Gimoti

Gimoti is protected by 5 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8334281 Nasal formulations of metoclopramide 16 May, 2030
(5 years from now)
Active
US11020361 Nasal formulations of metoclopramide 22 Dec, 2029
(4 years from now)
Active
US11628150 Nasal formulations of metoclopramide 22 Dec, 2029
(4 years from now)
Active
US11813231 Nasal formulations of metoclopramide 22 Dec, 2029
(4 years from now)
Active
US6770262 Nasal administration of agents for the treatment of gastroparesis 29 Mar, 2021
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Gimoti's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List